Cellectar Biosciences, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Cellectar Biosciences, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2010 to Q3 2024.
  • Cellectar Biosciences, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 40.6M shares, a 309% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 40.6M +30.6M +309% Sep 30, 2024 10-Q 2024-11-18
Q2 2024 35.8M +26.1M +268% Jun 30, 2024 10-Q 2024-10-29
Q1 2024 33.2M +23.4M +240% Mar 31, 2024 10-Q/A 2024-10-29
Q4 2023 20.7M +11.4M +121% Dec 31, 2023 10-Q 2024-11-18
Q3 2023 9.92M +3.81M +62.3% Sep 30, 2023 10-K/A 2024-10-29
Q2 2023 9.74M +3.63M +59.4% Jun 30, 2023 10-K/A 2024-10-29
Q1 2023 9.74M +3.63M +59.4% Mar 31, 2023 10-K/A 2024-10-29
Q4 2022 9.39M +3.28M +53.6% Dec 31, 2022 10-K/A 2024-10-29
Q3 2022 6.11M -55M -90% Sep 30, 2022 10-K/A 2024-10-29
Q2 2022 6.11M -49.2M -88.9% Jun 30, 2022 10-K/A 2024-10-29
Q1 2022 6.11M -46.6M -88.4% Mar 31, 2022 10-K/A 2024-10-29
Q4 2021 6.11M -39.3M -86.6% Dec 31, 2021 10-K 2023-03-09
Q3 2021 61.1M +34.3M +128% Sep 30, 2021 10-Q 2021-11-08
Q2 2021 55.3M +29.8M +117% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 52.7M +43.3M +461% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 45.4M +36.1M +384% Dec 31, 2020 10-K 2022-03-21
Q3 2020 26.8M +17.4M +186% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 25.5M +16.1M +171% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 9.4M +4.31M +84.7% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 9.39M +4.65M +98.4% Dec 31, 2019 10-K 2021-03-02
Q3 2019 9.39M +5.12M +120% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 9.39M +7.61M +429% Jun 30, 2019 10-Q 2019-08-12
Q1 2019 5.09M -12M -70.3% Mar 31, 2019 10-Q 2019-05-06
Q4 2018 4.73M +3.07M +184% Dec 31, 2018 10-K 2020-03-09
Q3 2018 4.27M -9.21M -68.3% Sep 30, 2018 10-Q 2018-11-13
Q2 2018 1.77M -11.7M -86.8% Jun 30, 2018 10-Q 2018-08-10
Q1 2018 17.1M +3.64M +27.1% Mar 31, 2018 10-Q 2018-05-11
Q4 2017 1.67M -8.7M -83.9% Dec 31, 2017 10-K 2019-02-26
Q3 2017 13.5M +8.11M +151% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 13.5M +8.09M +151% Jun 30, 2017 10-Q 2017-08-14
Q1 2017 13.5M +12.6M +1469% Mar 31, 2017 10-Q 2017-05-11
Q4 2016 10.4M +9.51M +1108% Dec 31, 2016 10-K 2018-03-21
Q3 2016 5.37M -2.2M -29% Sep 30, 2016 10-Q 2016-11-10
Q2 2016 5.37M -2.19M -29% Jun 30, 2016 10-Q 2016-08-11
Q1 2016 858K -6.7M -88.7% Mar 31, 2016 10-Q 2016-05-12
Q4 2015 858K +102K +13.5% Dec 31, 2015 10-K 2017-03-15
Q3 2015 7.56M +1.37K +0.02% Sep 30, 2015 10-Q 2015-11-12
Q2 2015 7.56M +4.69M +164% Jun 30, 2015 10-Q 2015-08-12
Q1 2015 7.56M -49.8M -86.8% Mar 31, 2015 10-Q 2015-05-20
Q4 2014 756K -2.11M -73.6% Dec 31, 2014 10-K/A 2016-10-20
Q3 2014 7.56M -49.8M -86.8% Sep 30, 2014 10-Q/A 2015-05-20
Q2 2014 2.87M -54.5M -95% Jun 30, 2014 10-Q 2014-08-04
Q1 2014 57.4M 0 0% Mar 31, 2014 10-Q 2014-05-14
Q4 2013 2.87M -43.5M -93.8% Dec 31, 2013 10-K/A 2015-05-20
Q3 2013 57.4M +13.9M +32.1% Sep 30, 2013 10-Q 2013-11-13
Q2 2013 57.4M +14.2M +32.9% Jun 30, 2013 10-Q 2013-08-12
Q1 2013 57.4M +20.4M +55.3% Mar 31, 2013 10-Q 2013-05-15
Q4 2012 46.4M +9.49M +25.7% Dec 31, 2012 10-K 2014-03-19
Q3 2012 43.5M +16.6M +62% Sep 30, 2012 10-Q 2012-11-06
Q2 2012 43.2M +16.4M +61% Jun 30, 2012 10-Q 2012-08-09
Q1 2012 37M Mar 31, 2012 10-Q 2012-05-04
Q4 2011 36.9M +24.1M +188% Dec 31, 2011 10-K 2013-03-28
Q3 2011 26.8M Sep 30, 2011 10-Q 2011-11-07
Q2 2011 26.8M Jun 30, 2011 10-Q 2011-08-12
Q4 2010 12.8M Dec 31, 2010 10-K 2012-03-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.